Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression

被引:41
作者
Stanzione, R
Picascia, A
Chieffi, P
Imbimbo, C
Palmieri, A
Mirone, V
Staibano, S
Franco, R
De Rosa, G
Schlessinger, J
Tramontano, D
机构
[1] Univ Naples Federico II, Dipartimento Biol & Patol Mol & Cellulare Luigi C, I-80131 Naples, Italy
[2] Univ Naples Federico II, Ctr Endocrinol & Oncol Sperimentale, CNR, I-80131 Naples, Italy
[3] Univ Naples Federico II, Urol Clin, I-80131 Naples, Italy
[4] Univ Naples Federico II, Dipartimento Sci Biomorfol & Funz, Sez Patol, I-80131 Naples, Italy
[5] Univ Sannio, Fac Sci, Benevento, Italy
[6] Univ Catanzaro Magna Graecia, Dipartimento Med Sperimentale & Clin Gaetano Salv, Catanzaro, Italy
[7] NYU Med Ctr, Dept Pharmacol, New York, NY 10016 USA
关键词
D O I
10.1038/labinvest.3780211
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Proline-rich kinase 2 (Pyk2), also known as CAK beta (cell adhesion kinase beta), is a cytoplasmic tyrosine kinase that is structurally related to focal adhesion kinase. Pyk2 is expressed in different cell types including brain cells, fibroblasts, platelets, and other hemopoietic cells. Pyk2 is rapidly tyrosine phosphorylated in response to diverse extracellular signals acting via different post receptor pathways. We have investigated whether this protein kinase is functionally expressed in normal and neoplastic prostate tissues. In this study, we demonstrate that Pyk2 is expressed only in normal epithelial prostate tissue and in benign prostatic hyperplasia, whereas its expression progressively declines with an increasing grade of malignancy of prostate cancer.
引用
收藏
页码:51 / 59
页数:9
相关论文
共 50 条
  • [41] Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): Structure-activity relationships and strategies for the elimination of reactive metabolite formation
    Walker, Daniel P.
    Bi, F. Christopher
    Kalgutkar, Amit S.
    Bauman, Jonathan N.
    Zhao, Sabrina X.
    Soglia, John R.
    Aspnes, Gary E.
    Kung, Daniel W.
    Klug-McLeod, Jacquelyn
    Zawistoski, Michael P.
    McGlynn, Molly A.
    Oliver, Robert
    Dunn, Matthew
    Li, Jian-Cheng
    Richter, Daniel T.
    Cooper, Beth A.
    Kath, John C.
    Hulford, Catherine A.
    Autry, Christopher L.
    Luzzio, Michael J.
    Ung, Ethan J.
    Roberts, W. Gregory
    Bonnette, Peter C.
    Buckbinder, Leonard
    Mistry, Anil
    Griffor, Matthew C.
    Han, Seungil
    Guzman-Perez, Angel
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (23) : 6071 - 6077
  • [42] Podosomes in osteoclast-like cells:: structural analysis and cooperative roles of paxillin, proline-rich tyrosine kinase 2 (Pyk2) and integrin αVβ3
    Pfaff, M
    Jurdic, P
    [J]. JOURNAL OF CELL SCIENCE, 2001, 114 (15) : 2775 - 2786
  • [43] Prolin-rich tyrosine kinase 2 (PYK2) expression and localization in mouse testis
    Chieffi, P
    Barchi, M
    Di Agostino, S
    Rossi, P
    Tramontano, D
    Geremia, R
    [J]. MOLECULAR REPRODUCTION AND DEVELOPMENT, 2003, 65 (03) : 330 - 335
  • [44] Proline-rich tyrosine kinase 2 regulates proliferation and differentiation of prostate cells
    Picascia, A
    Stanzione, R
    Chieffi, P
    Kisslinger, A
    Dikic, I
    Tramontano, D
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 186 (01) : 81 - 87
  • [45] RETRACTED: Proline-Rich Tyrosine Kinase 2 (Pyk2) Regulates IGF-I-Induced Cell Motility and Invasion of Urothelial Carcinoma Cells (Retracted Article)
    Genua, Marco
    Xu, Shi-Qiong
    Buraschi, Simone
    Peiper, Stephen C.
    Gomella, Leonard G.
    Belfiore, Antonino
    Iozzo, Renato V.
    Morrione, Andrea
    [J]. PLOS ONE, 2012, 7 (06):
  • [46] Retraction Note To: Functional activation of Proline-rich Tyrosine Kinase2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
    Meiying Wang
    Hongsheng Sun
    Wei Zhang
    Yuanchao Zhang
    [J]. BMC Musculoskeletal Disorders, 16
  • [47] Differential regulation of proline-rich tyrosine kinase 2 cell adhesion kinase beta (PYK2/CAK beta) and pp125(FAK) by glutamate and depolarization in rat hippocampus
    Siciliano, JC
    Toutant, M
    Derkinderen, P
    Sasaki, T
    Girault, JA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) : 28942 - 28946
  • [48] TCR engagement induces proline-rich tyrosine kinase-2 (Pyk2) translocation to the T cell-APC interface independently of Pyk2 activity and in an immunoreceptor tyrosine-based activation motif-mediated fashion
    Sancho, D
    Montoya, MC
    Monjas, A
    Gordón-Alonso, M
    Katagiri, T
    Gil, D
    Tejedor, R
    Alarcón, B
    Sánchez-Madrid, F
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (01) : 292 - 300
  • [49] Fibronectin fragment activation of proline-rich tyrosine kinase PYK2 mediates integrin signals regulating collagenase-3 expression by human chondrocytes through a protein kinase C-dependent pathway
    Loeser, RF
    Forsyth, CB
    Samarel, AM
    Im, HJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (27) : 24577 - 24585
  • [50] Down-regulation by antisense oligonucleotides establishes a role for the proline-rich tyrosine kinase PYK2 in angiotensin II-induced signaling in vascular smooth muscle
    Rocic, P
    Lucchesi, PK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) : 21902 - 21906